Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ClearFlow (formerly Clear Catheter Solutions) is a medical device company that develops and commercializes proprietary technologies to prevent catheter and surgical tube clogging. The company's flagship product, the PleuraFlow Active Clearance Technology (ACT) System, is the only FDA-cleared and CE-marked device designed to proactively maintain chest tube patency after heart and lung surgery. By preventing the accumulation of retained blood and fluids, ClearFlow's solutions reduce the risk of serious post-operative complications such as Retained Blood Syndrome (RBS) and pericardial tamponade. Headquartered in Irvine, California, the company also offers the ClearFix Rigid Sternal Fixation system and is expanding its anti-clogging platform into other medical applications, including urinary and enteral drainage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clear Catheter Solutions.